Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
27.3M
-
Shares change
-
-1.6M
-
Total reported value, excl. options
-
$246M
-
Value change
-
-$14M
-
Put/Call ratio
-
1.19
-
Number of buys
-
39
-
Number of sells
-
-41
-
Price
-
$9.03
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2016
114 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q2 2016.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.3M shares
of 386M outstanding shares and own 7.06% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (4.25M shares), LEVIN CAPITAL STRATEGIES, L.P. (3.6M shares), FRANKLIN RESOURCES INC (1.99M shares), WASATCH ADVISORS INC (1.9M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (1.78M shares), ORBIMED ADVISORS LLC (1.75M shares), Emerald Acquisition Ltd. (1.44M shares), VANGUARD GROUP INC (1.08M shares), Neuberger Berman Group LLC (926K shares), and Capital World Investors (800K shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.